This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Surgery for Parkinson's disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • bilateral subthalamic nucleus stimulation or bilateral globus pallidus interna stimulation may be used in people with PD who:
    • have motor complications that are refractory to best medical treatment,
    • are biologically fit with no clinically significant active comorbidity,
    • are levodopa responsive and
    • have no clinically significant active mental health problems, for example, depression or dementia
  • with the current evidence it is not possible to decide if the subthalamic nucleus or globus pallidus interna is the preferred target for deep brain stimulation for people with PD, or whether one form of surgery is more effective or safer than the other.

Patient-controlled high frequency stimulation of the thalamus may control tremor.

  • thalamic deep brain stimulation may be considered as an option in people with PD who predominantly have severe disabling tremor and where STN stimulation cannot be performed

Transplantation of foetal substantia nigra tissue is an experimental therapy.

Reference:

  1. Parkinson’s Disease.National clinical guideline for diagnosis and management in primary and secondary care. NICE full guideline.2006 http://www.nice.org.uk/

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.